← All Sponsors
SPONSOR

The George Institute

Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Type 2 DiabetesIgA NephropathyESRDGlomerulonephritisKidney Diseases
NCT05345327 Phase 3
Recruiting

SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes

Type 2 Diabetes
Australia, Sri Lanka View Trial →
NCT05434325
Recruiting

TESTING -ON Post-Trial ObservatioNal Cohort Study

IgA Nephropathy
Australia, Canada, China View Trial →